PVLA · Palvella Therapeutics, Inc. · Proposed Sales
Market Cap
$2.18B
Shares
14.41M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-09-02 | CHRISTOPHER KIRITSY | Director | 375 | 2026-09-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-19 | Goin Kathleen | Officer | 4,302 | 2026-08-19 | Piper Sandler & Co Inc |
| 2026-07-15 | Goin Kathleen | Officer | 4,302 | 2026-07-15 | Piper Sandler & Co Inc |
| 2026-06-17 | Goin Kathleen | Officer | 4,302 | 2026-06-17 | Piper Sandler & Co Inc |
| 2026-05-20 | Goin Kathleen | Officer | 4,302 | 2026-05-20 | Piper Sandler & Co Inc |
| 2026-04-15 | Goin Kathleen | Officer | 4,302 | 2026-04-15 | Piper Sandler & Co Inc |
| 2026-03-18 | Goin Kathleen | Officer | 4,302 | 2026-03-18 | Piper Sandler and Co |
| 2026-02-18 | Goin Kathleen | Officer | 4,301 | 2026-02-18 | Piper Sandler and Co |
| 2026-01-21 | Goin Kathleen | Officer | 4,302 | 2026-01-21 | Piper Sandler & Co Inc |
| 2025-12-17 | Goin Kathleen | Officer | 4,302 | 2025-12-17 | Piper Sandler & Co Inc |
| 2025-11-19 | Goin Kathleen | Officer | 4,302 | 2025-11-19 | Piper Sandler & Co Inc |
Showing 1–11 of 11 filings
Key facts
CIK
1583648
CUSIP
697947109
13F (30d)
130 filings
130 filers
Visit website
Investor relations